ART ships first of two molecular imaging systems to NCI

09/17/2008 | TMC Internet Telephony

ART Advanced Research Technologies, a Canadian medical-device and imaging firm, said it has shipped the first of two Optix MX2 systems ordered by the National Cancer Institute-Frederick in Maryland. "We are very proud to see that the NCI has chosen our Optix molecular imaging systems to conduct its world-class research and to have them among our growing base of clients," ART Chairman and CEO Sebastien Gignac said.

View Full Article in:

TMC Internet Telephony

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA